BrainsWay Ltd. (BWAY)
USD 8.78
(-3.3%)
USD 8.78
(-3.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 15.31 Million USD | -19.74% |
| 2022 | 19.08 Million USD | 3.65% |
| 2021 | 18.4 Million USD | 28.04% |
| 2020 | 14.37 Million USD | -0.96% |
| 2019 | 14.51 Million USD | -12.82% |
| 2018 | 16.65 Million USD | 16.36% |
| 2017 | 14.3 Million USD | 47.87% |
| 2016 | 9.67 Million USD | 3.52% |
| 2015 | 9.34 Million USD | -8.3% |
| 2014 | 10.19 Million USD | 219.03% |
| 2013 | 3.19 Million USD | 90.21% |
| 2012 | 1.67 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 16.56 Million USD | -2.14% |
| 2024 Q1 | 17.3 Million USD | 8.2% |
| 2023 Q1 | 19.03 Million USD | -0.22% |
| 2023 FY | 15.31 Million USD | -19.74% |
| 2023 Q4 | 15.31 Million USD | -17.47% |
| 2023 Q2 | 17.89 Million USD | -6.02% |
| 2023 Q3 | 18.55 Million USD | 3.71% |
| 2022 Q4 | 19.08 Million USD | 1.73% |
| 2022 FY | 19.08 Million USD | 3.65% |
| 2022 Q2 | 18.09 Million USD | 3.51% |
| 2022 Q1 | 17.48 Million USD | -5.03% |
| 2022 Q3 | 18.75 Million USD | 3.65% |
| 2021 Q2 | 14.81 Million USD | 0.35% |
| 2021 Q1 | 14.76 Million USD | 2.71% |
| 2021 FY | 18.4 Million USD | 28.04% |
| 2021 Q3 | 15.82 Million USD | 6.79% |
| 2021 Q4 | 18.4 Million USD | 16.32% |
| 2020 Q4 | 14.37 Million USD | -0.64% |
| 2020 Q2 | 14.55 Million USD | 4.34% |
| 2020 Q3 | 14.46 Million USD | -0.56% |
| 2020 Q1 | 13.94 Million USD | -3.93% |
| 2020 FY | 14.37 Million USD | -0.96% |
| 2019 Q3 | 14.58 Million USD | -2.06% |
| 2019 FY | 14.51 Million USD | -12.82% |
| 2019 Q2 | 14.89 Million USD | -21.16% |
| 2019 Q1 | 18.89 Million USD | 13.47% |
| 2019 Q4 | 14.51 Million USD | -0.49% |
| 2018 FY | 16.65 Million USD | 16.36% |
| 2018 Q4 | 16.65 Million USD | 15.56% |
| 2018 Q3 | 14.4 Million USD | 5.58% |
| 2018 Q2 | 13.64 Million USD | -0.79% |
| 2018 Q1 | 13.75 Million USD | -3.88% |
| 2017 FY | 14.3 Million USD | 47.87% |
| 2017 Q1 | 10.44 Million USD | 7.91% |
| 2017 Q2 | 9.09 Million USD | -12.87% |
| 2017 Q3 | 9.52 Million USD | 4.72% |
| 2017 Q4 | 14.3 Million USD | 50.19% |
| 2016 Q1 | 9.73 Million USD | 4.14% |
| 2016 FY | 9.67 Million USD | 3.52% |
| 2016 Q4 | 9.67 Million USD | -1.71% |
| 2016 Q3 | 9.84 Million USD | 4.7% |
| 2016 Q2 | 9.4 Million USD | -3.41% |
| 2015 Q3 | 9.26 Million USD | 1.29% |
| 2015 Q2 | 9.14 Million USD | -76.75% |
| 2015 Q1 | 39.35 Million USD | 286.03% |
| 2015 FY | 9.34 Million USD | -8.3% |
| 2015 Q4 | 9.34 Million USD | 0.89% |
| 2014 Q4 | 10.19 Million USD | 153.05% |
| 2014 Q2 | 4.03 Million USD | 15.43% |
| 2014 FY | 10.19 Million USD | 219.03% |
| 2014 Q3 | 4.02 Million USD | -0.2% |
| 2014 Q1 | 3.49 Million USD | 9.44% |
| 2013 Q2 | 2.89 Million USD | 31.18% |
| 2013 Q1 | 2.21 Million USD | 31.57% |
| 2013 Q3 | 3.23 Million USD | 11.6% |
| 2013 Q4 | 3.19 Million USD | -1.25% |
| 2013 FY | 3.19 Million USD | 90.21% |
| 2012 Q3 | 4.85 Million USD | 0.0% |
| 2012 FY | 1.67 Million USD | 0.0% |
| 2012 Q4 | 1.67 Million USD | -65.43% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 70.121% |
| Cerus Corporation | 144.3 Million USD | 89.388% |
| Envoy Medical, Inc. | 9.4 Million USD | -62.88% |
| electroCore, Inc. | 8.94 Million USD | -71.202% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -186.672% |
| IceCure Medical Ltd | 4.24 Million USD | -260.584% |
| Inogen, Inc. | 121.38 Million USD | 87.384% |
| OrthoPediatrics Corp. | 72.56 Million USD | 78.895% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 48.23% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -381.278% |
| MaxCyte, Inc. | 36.1 Million USD | 57.587% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -728.72% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -3500.913% |
| Orthofix Medical Inc. | 326.58 Million USD | 95.311% |
| PAVmed Inc | 57.13 Million USD | 73.198% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 39.858% |
| RxSight, Inc. | 22.18 Million USD | 30.981% |
| Sight Sciences, Inc. | 46.43 Million USD | 67.021% |
| SI-BONE, Inc. | 61.05 Million USD | 74.916% |
| TELA Bio, Inc. | 59.16 Million USD | 74.117% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 86.563% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -48.406% |
| Acutus Medical, Inc. | 54.83 Million USD | 72.075% |
| Talis Biomedical Corporation | 29.22 Million USD | 47.598% |
| Spectral AI, Inc. | 12.4 Million USD | -23.49% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 33.803% |
| CVRx, Inc. | 39.28 Million USD | 61.015% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -28.064% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -530.387% |
| Bioventus Inc. | 589.79 Million USD | 97.403% |
| Venus Concept Inc. | 107.1 Million USD | 85.702% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 70.358% |
| LivaNova PLC | 1.15 Billion USD | 98.671% |
| 908 Devices Inc. | 37.49 Million USD | 59.152% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 97.823% |
| Nemaura Medical Inc. | 26.37 Million USD | 41.943% |
| NeuroPace, Inc. | 86.99 Million USD | 82.397% |
| LENSAR, Inc. | 22.4 Million USD | 31.661% |
| Apyx Medical Corporation | 52.31 Million USD | 70.729% |
| Cutera, Inc. | 518.12 Million USD | 97.044% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 47.784% |
| BioSig Technologies, Inc. | 4.68 Million USD | -226.873% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 73.763% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 28.732% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.302% |
| Axonics, Inc. | 82.35 Million USD | 81.406% |
| Outset Medical, Inc. | 190.91 Million USD | 91.979% |
| IRIDEX Corporation | 24.91 Million USD | 38.533% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 87.647% |
| IRadimed Corporation | 20.73 Million USD | 26.148% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -814.815% |
| INVO Bioscience, Inc. | 19.99 Million USD | 23.411% |
| Telesis Bio, Inc. | 40.87 Million USD | 62.533% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 62.457% |
| Varex Imaging Corporation | 668.6 Million USD | 97.71% |
| Quipt Home Medical Corp. | 136.29 Million USD | 88.764% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -328.723% |
| Pulmonx Corporation | 60.63 Million USD | 74.744% |
| Dynatronics Corporation | 11.78 Million USD | -29.999% |
| Modular Medical, Inc. | 2.27 Million USD | -574.032% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -276.821% |
| Semler Scientific, Inc. | 6.27 Million USD | -144.242% |
| InMode Ltd. | 75.91 Million USD | 79.827% |
| Bruker Corporation | 2.83 Billion USD | 99.46% |
| Cytosorbents Corporation | 29.98 Million USD | 48.929% |
| DexCom, Inc. | 4.19 Billion USD | 99.635% |
| Align Technology, Inc. | 2.45 Billion USD | 99.376% |
| Viveve Medical, Inc. | 10.84 Million USD | -41.182% |
| ZimVie Inc. | 795.85 Million USD | 98.076% |
| Movano Inc. | 5.97 Million USD | -156.43% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 85.36% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -3500.913% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -28.064% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 97.604% |
| Profound Medical Corp. | 12.66 Million USD | -20.908% |
| Insulet Corporation | 1.85 Billion USD | 99.175% |
| enVVeno Medical Corporation | 2.43 Million USD | -528.912% |
| Surmodics, Inc. | 65.82 Million USD | 76.735% |
| iCAD, Inc. | 8 Million USD | -91.401% |
| Nuwellis, Inc. | 6.78 Million USD | -125.87% |
| Biotricity, Inc. | 35.91 Million USD | 57.366% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 93.134% |
| Aethlon Medical, Inc. | 2.47 Million USD | -517.587% |
| InspireMD, Inc. | 8.14 Million USD | -88.086% |
| PAVmed Inc. | 57.13 Million USD | 73.198% |
| BIOLASE, Inc. | 35.34 Million USD | 56.676% |
| Beyond Air, Inc. | 29.77 Million USD | 48.568% |
| FONAR Corporation | 57.45 Million USD | 73.347% |
| AxoGen, Inc. | 101.16 Million USD | 84.862% |
| Vivani Medical, Inc. | 25.03 Million USD | 38.832% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 82.557% |
| Inari Medical, Inc. | 209.32 Million USD | 92.684% |
| UFP Technologies, Inc. | 118.04 Million USD | 87.027% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -20.673% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -600.609% |
| Tenon Medical, Inc. | 5.56 Million USD | -175.085% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -760.821% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 13.157% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.514% |
| Sintx Technologies, Inc. | 6.59 Million USD | -132.277% |
| NanoVibronix, Inc. | 2.68 Million USD | -470.141% |
| Quanterix Corporation | 78.08 Million USD | 80.388% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -328.723% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -213.49% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.534% |
| TransMedics Group, Inc. | 568.84 Million USD | 97.308% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 8.2% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1048.73% |
| Hyperfine, Inc. | 9.8 Million USD | -56.265% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 93.88% |
| Biomerica, Inc. | 2.66 Million USD | -475.066% |
| Bone Biologics Corporation | 831.4 Thousand USD | -1741.949% |
| AVITA Medical, Inc. | 19.86 Million USD | 22.911% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -675.91% |
| Silk Road Medical, Inc | 114.15 Million USD | 86.585% |